Home > Boards > Canadian > Medical - Healthcare >

GeneNews Ltd. (TSX:GEN)

Add TSX:GEN Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 9/7/2017 7:39:04 PM - Followers: 0 - Board type: Free - Posts Today: 0

"GeneNews, an innovator in the liquid biopsy space, is committed to becoming a leader in advanced diagnostics and personalized medicine, serving as a strong commercialization outlet for early detection of cancer and other chronic diseases. Our mission is to identify, assess and make commercially available a comprehensive menu of diagnostics that provide physicians and patients with personalized clinical intelligence and actionable information to improve health out-comes through the early diagnosis of disease. Our Richmond, Virginia-based Innovative Diagnostic Laboratory clinical reference lab specializes in traditional and advanced clinical evidence-based blood testing that helps find, understand, and address cancer risk in patient populations. Currently, IDL offers risk assessment blood tests for four prevalent cancer types - colon, lung, prostate and breast. GeneNews' common shares trade on the Toronto Stock Exchange under the symbol 'GEN'. More information on GeneNews and IDL can be found at and, respectively."
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
TSX:GEN News: Current Report Filing (8-k) 01/16/2018 04:16:37 PM
TSX:GEN News: Genesis HealthCare Raises Over $222,000 as a Gold Level National Team for Alzheimer’s Association Walk to End Alzheimer’s... 01/16/2018 11:39:22 AM
TSX:GEN News: Current Report Filing (8-k) 01/10/2018 04:53:24 PM
TSX:GEN News: GeneNews Announces Letter to Shareholders from CEO 01/05/2018 10:01:00 AM
TSX:GEN News: GeneNews Announces Letter to Shareholders from CEO 01/05/2018 10:01:00 AM